P4HA1: an important target for treating fibrosis related diseases and cancer
Fibrosis is significantly associated with a wide variety of diseases and is involved in their progression. Fibrosis activated under the influence of different combinations of factors is considered a double-edged sword. Although there has been much research on organ fibrosis in recent years, a variet...
Saved in:
| Main Authors: | Xuewen Yang, Dong Zhang, Mengmeng Li, Yingchun Shao, Xiyang Zhang, Yongzhi Xue |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1493420/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial Cell‐Specific Prolyl Hydroxylase‐2 Deficiency Augments Angiotensin II–Induced Arterial Stiffness and Cardiac Pericyte Recruitment in Mice
by: Bo Liu, et al.
Published: (2024-08-01) -
Issues on clinical application of hypoxia-inducible factor prolyl hydroxylase inhibitor Roxadustat
by: TU Yan, et al.
Published: (2020-01-01) -
A Case Report of Hypothyrotropin Hypothyroidism Caused by Roxadustat
by: YAN Xuelian, et al.
Published: (2025-03-01) -
Study on HIF-PHI combined with iron supplement in treatment of renal anemia in rats
by: Zhaoli Gao, et al.
Published: (2025-03-01) -
Progress of HIF-1α and HIF-PHI in vascular calcification of chronic kidney disease
by: WANG Ao, et al.
Published: (2024-08-01)